Medvi Tirzepatide Cost Guide: Affordable Pricing and Value Breakdown

Professional () hero image with 'medvi tirzepatide cost' in crisp white centered on a semi-transparent dark navy panel, 8%

Last updated: October 13, 2026

Quick Answer: Medvi tirzepatide cost starts at $279 for the first month and rises to $399 per month from month two onward for compounded tirzepatide injections. Prepaid multi-month bundles can reduce the effective monthly rate to around $249. The program is cash-pay and includes telehealth visits, care planning, and free shipping bundled into the price. [1][2][8]


Key Takeaways

  • Medvi compounded tirzepatide costs $279 for the first month and $399/month after that for injections [8][10]
  • Tablet form adds approximately $70 to the base price at each tier [1]
  • Multi-month prepaid bundles (3-, 6-, and 12-month) can lower the effective monthly cost to around $249 [3][4]
  • Medvi charges a flat $399/month regardless of dose tier, from 2.5 mg through 15 mg, which is a value advantage at higher doses
  • Insurance is generally not accepted for compounded programs; this is a cash-pay service [6][8]
  • The monthly fee bundles telehealth visits, physician review, a metabolic report, care planning, and free shipping [5][6]
  • Compounded tirzepatide from competing telehealth providers can start as low as $149/month, so Medvi sits at the higher end of the market
  • Brand-name tirzepatide (Zepbound) through Medvi requires a $99 membership fee plus separate pharmacy costs
  • Stopping tirzepatide often leads to weight regain; most clinical guidance suggests long-term use for sustained results
  • A prescription is required; Medvi’s telehealth physicians issue prescriptions after an online consultation [6][8]

What Is Tirzepatide and How Does It Work

Tirzepatide is a dual-action injectable (and now oral) medication that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual mechanism suppresses appetite, slows gastric emptying, and improves insulin sensitivity, making it more potent than single-receptor GLP-1 drugs like semaglutide for many patients.

What Is Tirzepatide and How Does It Work

The brand-name version, Zepbound, was approved by the FDA for chronic weight management in adults with obesity or weight-related conditions. Compounded tirzepatide, offered through telehealth platforms like Medvi, uses the same active molecule but is prepared by licensed compounding pharmacies rather than the original manufacturer.

Key mechanism points:

  • Signals the brain to reduce hunger and food intake
  • Slows how quickly food leaves the stomach, extending fullness
  • Lowers post-meal blood sugar spikes
  • Reduces overall caloric intake without requiring willpower alone

Clinical trials published in the New England Journal of Medicine (2022) showed that tirzepatide produced average weight loss of up to 22.5% of body weight over 72 weeks at the highest dose, outperforming most other weight-loss medications studied to date.

For a broader look at how GLP-1 drugs reshape metabolism, see our GLP-1 transformation guide for 2026.


How Much Does Medvi Tirzepatide Cost Per Month

Medvi tirzepatide cost follows a two-tier structure: a discounted introductory month followed by a standard ongoing rate. As of October 2026, the pricing for compounded tirzepatide injections is $279 for month one and $399 per month from month two onward [8][10].

The tablet form costs slightly more. One detailed review notes that choosing the oral tablet option adds a flat $70 to the base price, making the introductory tablet cost approximately $349 and the ongoing tablet refill rate approximately $469 per month.

Medvi Compounded Tirzepatide Pricing Summary (October 2026):

Option Month 1 Month 2+ Prepaid Rate (est.)
Compounded Injection $279 $399 ~$249/mo
Compounded Tablet ~$349 ~$469 Varies
Brand-Name (Zepbound) $99 membership + pharmacy cost Varies N/A

For a deeper breakdown of monthly cost structures, see our dedicated Medvi tirzepatide monthly cost analysis.

What the monthly fee includes:

  • Telehealth physician consultation and prescription
  • Personalized care plan and metabolic report
  • The compounded medication itself
  • Free shipping on every order [5][6][8]

Is Medvi Tirzepatide Cheaper Than Other Brands and Telehealth Providers

Medvi is positioned toward the higher end of the compounded tirzepatide market. At $399/month for ongoing injections, Medvi costs more than several competing telehealth providers, where compounded tirzepatide programs can start near $149/month with auto-refill at entry doses.

Is Medvi Tirzepatide Cheaper Than Other Brands and Telehealth Providers

That said, Medvi’s flat-rate pricing across all dose tiers (2.5 mg through 15 mg) is a genuine value point for patients who escalate to higher doses. Some competitors charge more as doses increase, so a patient on 10 mg or 15 mg may actually pay less with Medvi than with a tiered-pricing provider.

Comparison context:

  • Lowest-cost compounded tirzepatide telehealth: ~$149/month (entry dose, auto-refill)
  • Medvi compounded tirzepatide: $399/month (flat, all doses)
  • Brand-name Zepbound (retail, no insurance): approximately $1,060/month (manufacturer list price as of 2026)
  • Wegovy (semaglutide, retail, no insurance): approximately $1,350/month (manufacturer list price as of 2026)

For a direct comparison of semaglutide and tirzepatide program costs, our cost of GLP-1 semaglutide and compounded tirzepatide guide breaks down the numbers side by side.

Choose Medvi if: you want an all-inclusive program with bundled care, prefer a flat rate that does not increase as your dose goes up, and value the convenience of a single monthly payment covering everything.

Consider alternatives if: your primary goal is the lowest possible monthly cost and you are comfortable managing telehealth visits separately from medication fulfillment.


What Are the Different Dosage Strengths and Prices

Medvi charges a flat $399/month for compounded tirzepatide regardless of which dose tier a patient is on. The standard escalation schedule starts at 2.5 mg and increases gradually up to a maximum of 15 mg, following the same titration approach used in clinical trials.

Standard tirzepatide dose escalation:

  1. 2.5 mg/week (weeks 1-4, starting dose)
  2. 5 mg/week (weeks 5-8)
  3. 7.5 mg/week (weeks 9-12)
  4. 10 mg/week (weeks 13-16)
  5. 12.5 mg/week (weeks 17-20)
  6. 15 mg/week (maintenance, if tolerated)

Because Medvi does not raise its price as doses escalate, a patient paying $399/month at 2.5 mg pays the same $399/month at 15 mg. This flat structure means the first-year cost on a standard escalation schedule runs approximately $4,788 (calculated as $279 for month one plus $399 for each of the remaining 11 months).

For more detail on how tirzepatide dosing affects total program costs, see our tirzepatide monthly cost breakdown.


Are There Coupons or Discounts for Medvi Tirzepatide

Yes, Medvi regularly offers introductory discounts and prepaid bundle savings. The most consistent discount is the reduced first-month price ($279 instead of $399), which functions as a built-in introductory offer [8][10].

Known discount structures (as of October 2026):

  • First-month discount: $279 vs. the standard $399 renewal rate [8][10]
  • Prepaid multi-month bundles: 3-month injection bundle at $1,047; 6-month at $2,514; 12-month at $4,788, which works out to approximately $349, $419, and $399 per month respectively [3][4]
  • Promotional codes: Some third-party review sites and affiliate partners publish codes that reduce the first month further, sometimes to $199 or lower [7]
  • Retention discounts: Users who contact Medvi’s support team about canceling have reported receiving additional discount offers to stay on the program [7]

One independent reviewer documented paying $199 for the first month using an automatic discount code, then seeing a default renewal price of $299 in the portal before a retention discount was applied [7]. This pattern is worth knowing before you sign up, so you can plan for the standard $399 renewal rate rather than assuming the introductory price continues.

Pro tip: If you plan to stay on tirzepatide for at least three months, the prepaid bundle typically offers a better effective monthly rate than paying month-to-month.

Start your Medvi tirzepatide program at the current introductory rate


Does Insurance Cover Medvi Tirzepatide

Medvi operates as a cash-pay telehealth service, and insurance is generally not accepted for compounded tirzepatide programs [6][8]. The monthly fee covers the medication, telehealth visits, and care management as a bundled cash-pay subscription.

Brand-name tirzepatide (Zepbound) prescribed through Medvi’s $99 membership model may be eligible for separate insurance reimbursement at an outside pharmacy, depending on your plan. However, most commercial insurance plans in 2026 still restrict GLP-1 coverage for weight loss (as opposed to type 2 diabetes), and Medicare does not cover GLP-1 drugs for weight management.

Insurance reality check:

  • Compounded tirzepatide: almost never covered by insurance (it is not an FDA-approved drug product)
  • Brand-name Zepbound: covered by some commercial plans with prior authorization; rarely covered by Medicare for weight loss
  • HSA/FSA funds: may be used for prescription medications including compounded tirzepatide, though you should confirm with your plan administrator

For guidance on finding GLP-1 coverage, our most affordable GLP-1 covered by insurance guide explains which plans and pathways offer the best chance of reimbursement.


Can You Get Tirzepatide Cheaper Through Compounding Pharmacies

Yes, compounding pharmacies working directly with patients or through lower-cost telehealth platforms can offer compounded tirzepatide at significantly lower prices than Medvi’s $399/month rate.

Can You Get Tirzepatide Cheaper Through Compounding Pharmacies

Entry-level compounded tirzepatide programs from competing providers start near $149/month at the 2.5 mg starting dose, though prices often increase as doses escalate. The total cost over a 12-month escalation schedule at a tiered-pricing competitor may end up comparable to or higher than Medvi’s flat $399 rate, depending on the provider.

What to know about compounding pharmacy pricing:

  • Quality and potency can vary between compounding pharmacies; look for 503A or 503B accredited facilities
  • Lower-cost providers may not include bundled telehealth visits, care management, or metabolic reporting
  • Some platforms charge separately for the prescription consultation ($50-$150) and the medication

For a full comparison of compounding pharmacy options, see our tirzepatide compounding pharmacy cost guide and our overview of compounded tirzepatide: what you need to know.

Compare Medvi’s all-inclusive pricing against the competition


How Much Weight Can You Lose With Tirzepatide

Clinical trial data shows tirzepatide produces some of the largest weight-loss results of any medication studied for obesity. In the SURMOUNT-1 trial (published in the New England Journal of Medicine, 2022), participants on the highest dose (15 mg/week) lost an average of 22.5% of their body weight over 72 weeks, compared with 2.4% in the placebo group.

Realistic expectations by dose:

  • 5 mg/week: average ~15% body weight loss over 72 weeks
  • 10 mg/week: average ~19.5% body weight loss over 72 weeks
  • 15 mg/week: average ~22.5% body weight loss over 72 weeks

Real-world results vary. Factors that affect outcomes include starting weight, diet quality, physical activity, dose tolerance, and how long you stay on the medication. Many Medvi users report meaningful weight loss within the first 8-12 weeks, with the most significant results accumulating over six months to a year.

For patient-reported outcomes and real-world stories, our tirzepatide reviews by patients page collects firsthand accounts across dose levels and program lengths.


What Is the Difference Between Tirzepatide and Semaglutide Pricing

Tirzepatide and semaglutide are both GLP-1 receptor agonists, but tirzepatide also activates the GIP receptor, which generally produces stronger weight-loss results. On the pricing side, compounded semaglutide programs typically cost less than compounded tirzepatide at equivalent dose stages.

General pricing comparison (compounded, cash-pay, 2026 estimates):

  • Compounded semaglutide: approximately $149-$299/month depending on provider and dose
  • Compounded tirzepatide (Medvi): $399/month flat
  • Brand-name semaglutide (Wegovy): approximately $1,350/month retail without insurance
  • Brand-name tirzepatide (Zepbound): approximately $1,060/month retail without insurance

Medvi’s compounded tirzepatide costs more per month than most compounded semaglutide programs, but many patients find the stronger efficacy justifies the difference. For a direct cost comparison, see our how much does semaglutide cost in 2026 guide.


Does Medvi Tirzepatide Require a Prescription

Yes, tirzepatide in any form requires a valid prescription from a licensed physician. Medvi’s program includes a telehealth consultation as part of the monthly fee, during which a physician reviews your health history, current medications, and weight-loss goals before issuing a prescription [6][8].

The Medvi prescription process:

  1. Complete an online health intake form
  2. A licensed physician reviews your information (typically within 24-48 hours)
  3. If approved, a prescription is issued and sent to a compounding pharmacy
  4. Medication is shipped directly to your home
  5. Ongoing physician check-ins are included in the monthly subscription

You cannot purchase tirzepatide from Medvi without going through this consultation process. This is both a legal requirement and a safety measure, as tirzepatide is not appropriate for everyone.

Get started with a Medvi physician consultation today


What Are Common Side Effects and Is It Worth the Cost

The most common side effects of tirzepatide are gastrointestinal: nausea, vomiting, diarrhea, and constipation. These are most pronounced during dose escalation and typically improve as the body adjusts. In clinical trials, roughly 20-30% of participants experienced nausea, with most cases rated mild to moderate.

Common side effects:

  • Nausea (most common, especially in weeks 1-8)
  • Decreased appetite (often considered a benefit)
  • Diarrhea or constipation
  • Fatigue during dose escalation
  • Injection site reactions (for injectable form)

Less common but serious risks:

  • Pancreatitis (rare; stop use and seek care if severe abdominal pain occurs)
  • Gallbladder problems (increased risk with rapid weight loss)
  • Hypoglycemia (primarily in patients also taking insulin or sulfonylureas)
  • Thyroid C-cell tumors (observed in rodent studies; avoid if personal or family history of medullary thyroid carcinoma)

Is the cost worth it? For most patients who tolerate tirzepatide well and follow the program, the answer is yes. Losing 15-22% of body weight reduces risk of type 2 diabetes, cardiovascular disease, sleep apnea, and joint problems. The long-term health value of sustained weight loss typically exceeds the monthly program cost, especially when compared to the costs of managing obesity-related conditions.

For a full review of the Medvi platform’s user experience and value, see our Medvi oral tirzepatide reviews page.


Who Should Not Use Tirzepatide

Tirzepatide is not appropriate for everyone. Medvi’s physician consultation screens for contraindications, but it is important to know the key exclusions before applying.

Do not use tirzepatide if you have:

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • A history of pancreatitis
  • Severe gastrointestinal disease (e.g., gastroparesis)
  • Type 1 diabetes (tirzepatide is not indicated for T1D)
  • Pregnancy or plans to become pregnant (use effective contraception; stop tirzepatide at least 2 months before trying to conceive)

Use with caution if you:

  • Take insulin or sulfonylureas (hypoglycemia risk increases)
  • Have a history of gallbladder disease
  • Are under 18 years old (not approved for pediatric use)
  • Have kidney or liver impairment (dose adjustments may be needed)

Always disclose your full medication list during the Medvi consultation, as tirzepatide can interact with oral medications by slowing gastric emptying and affecting absorption timing.


How Long Do You Need to Take Tirzepatide and What Happens If You Stop

Tirzepatide is most effective as a long-term treatment, not a short-term fix. Clinical data and real-world experience consistently show that stopping tirzepatide leads to weight regain for most patients, often recovering a significant portion of lost weight within 12 months of discontinuation.

What happens when you stop:

  • Appetite returns to pre-treatment levels relatively quickly
  • Weight regain begins, typically within weeks to months
  • Metabolic improvements (blood sugar, blood pressure) may also reverse
  • The rate of regain varies by individual, diet, and activity level

Most clinical guidelines in 2026 treat obesity as a chronic condition requiring ongoing management, similar to hypertension or high cholesterol. This means tirzepatide is often prescribed indefinitely for patients who respond well and tolerate it without serious side effects.

Planning for long-term cost: At Medvi’s $399/month rate, a full year costs approximately $4,788 (accounting for the discounted first month). Patients who commit to multi-year use should factor this into their budget or explore prepaid bundle options to reduce the per-month rate.

Explore Medvi’s long-term program options and current pricing


Pros and Cons of Medvi Tirzepatide

Pros Cons
All-inclusive monthly fee (telehealth, care, shipping, medication) Higher monthly cost than many competitors ($399 vs. $149-$299 elsewhere)
Flat pricing regardless of dose tier (no price hike at higher doses) Cash-pay only; insurance not accepted for compounded programs
Both injection and tablet forms available Introductory pricing can be confusing; renewal rates higher than advertised “starting at” prices
Physician-supervised with ongoing care management Tablet form adds ~$70/month to base price
Discounted first month ($279) and prepaid bundle options Long-term cost is significant if used indefinitely
Medvi is a legitimate, licensed telehealth platform with verified physician oversight Compounded tirzepatide is not FDA-approved as a finished drug product

Medvi Tirzepatide Cost: FAQ

How much does Medvi tirzepatide cost per month in 2026? Medvi compounded tirzepatide costs $279 for the first month and $399/month from month two onward for injections. The tablet form adds approximately $70 to each month’s price. Prepaid multi-month bundles can lower the effective monthly rate to around $249. [8][10]

Does Medvi accept insurance for tirzepatide? No. Medvi’s compounded tirzepatide programs are cash-pay only. Insurance is not accepted for compounded medications. Brand-name Zepbound prescribed through Medvi’s membership model may be covered by some commercial insurance plans separately. [6][8]

Is Medvi tirzepatide the same as Zepbound? No. Medvi primarily offers compounded tirzepatide, which uses the same active molecule as Zepbound but is prepared by a licensed compounding pharmacy rather than the original manufacturer (Eli Lilly). Compounded tirzepatide is not an FDA-approved finished drug product. Medvi also offers access to brand-name Zepbound through a separate $99 membership model.

How long before I see weight-loss results with Medvi tirzepatide? Most patients notice reduced appetite within the first one to two weeks. Measurable weight loss typically begins within four to eight weeks. Significant results (10%+ body weight) generally require three to six months of consistent use at escalating doses.

Can I use HSA or FSA funds for Medvi tirzepatide? Prescription medications, including compounded tirzepatide, are generally eligible for HSA and FSA reimbursement. Confirm with your plan administrator before purchasing, as rules can vary by plan.

What happens if I stop taking Medvi tirzepatide? Stopping tirzepatide typically leads to weight regain as appetite returns to pre-treatment levels. Most patients regain a meaningful portion of lost weight within 12 months of stopping. Long-term or indefinite use is often recommended for sustained results.

Is Medvi a legitimate company? Yes. Medvi is a licensed telehealth platform that works with licensed physicians and accredited compounding pharmacies. It has been reviewed by major outlets including USA Today and has a presence on consumer review platforms. [8][10] For a detailed look at user experiences, see our Medvi reviews and complaints overview.

How does Medvi tirzepatide compare to semaglutide in cost? Compounded semaglutide programs typically cost $149-$299/month, making them cheaper than Medvi’s $399/month tirzepatide rate. However, tirzepatide generally produces greater weight loss, which may justify the higher cost for patients who want maximum efficacy. See our tirzepatide cost review for a full comparison.

Can I get a discount on my first month of Medvi tirzepatide? Yes. Medvi’s standard introductory price is $279 for the first month (down from the $399 renewal rate). Additional promotional codes are sometimes available through affiliate partners, potentially reducing the first month to $199 or lower. [7][8]

Does Medvi offer tirzepatide in pill form? Yes. Medvi offers compounded tirzepatide as both a subcutaneous injection and an oral tablet. The tablet option costs approximately $70 more per month than the injection. For details on the tablet formulation, see our Medvi tirzepatide tablets guide.

Check current Medvi tirzepatide pricing and availability


Conclusion

The Medvi tirzepatide cost guide makes one thing clear: at $279 for month one and $399/month thereafter, Medvi is a premium-priced but genuinely all-inclusive compounded tirzepatide program. The flat-rate pricing across all dose tiers is a real advantage for patients who escalate to higher doses, and the bundled care model means you are not paying separately for telehealth visits, care planning, or shipping.

If your priority is the lowest possible monthly cost, competing telehealth providers offer compounded tirzepatide starting near $149/month. But if you want a streamlined, physician-supervised program with no billing surprises at higher doses, Medvi’s structure is straightforward and well-suited to long-term use.

Actionable next steps:

  1. Use the $279 introductory month to assess your tolerance and early results before committing to a longer plan.
  2. If you plan to stay on tirzepatide for three or more months, compare the prepaid bundle rates against the month-to-month price to find the best effective monthly cost.
  3. Ask Medvi’s support team about current promotional codes before checkout; first-month discounts beyond the standard $279 are sometimes available.
  4. Confirm with your HSA or FSA administrator whether your account covers compounded prescription medications.
  5. If cost is the primary concern, review our cheapest tirzepatide online guide to compare all available options before deciding.

Start your Medvi tirzepatide program today and take the first step toward your weight-loss goals


References

[1] Weight Loss Program Tirzepatide Prescription Tablets 346 – https://store.medvi.org/catalogue/weight-loss-program-tirzepatide-prescription-tablets_346/?variant-id=301

[2] Weight Loss Program Compounded Tirzepatide Injection Prescription 339 – https://store.medvi.org/catalogue/weight-loss-program-compounded-tirzepatide-injection-prescription_339/

[3] Weight Loss 2 – https://store.medvi.org/catalogue/category/weight-loss_2/

[4] Catalogue – https://store.medvi.org/catalogue/

[5] Whgls Lp A1 – https://home.medvi.org/weightloss/whgls-lp-a1

[6] Tirz 166 – https://glp1.medvi.org/tirz-166

[7] Medvi Review Upsells Renewal Price – https://www.glpwinner.com/insights/medvi-review-upsells-renewal-price

[8] usatoday – https://www.usatoday.com/story/life/health-wellness/medvi-reviews/90183552007/

[9] Medvi – https://www.menomellow.com/reviews/medvi/

[10] Medvi – https://www.consumeraffairs.com/health/medvi.html


Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Tirzepatide is a prescription medication. Consult a licensed healthcare provider before starting any weight-loss medication program. Individual results vary.

Affiliate Disclosure: This article contains affiliate links. If you purchase through our links, we may earn a commission at no additional cost to you.


Christina Lewis

Similar Posts